CYTK
Cytokinetics Inc
65.80$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +34.6% | -7.2% | +27.1% | -33.7% | -64.9% | +335.6% | -8.8% | +556.5% | -96.8% | +55.2% | +89.0% | +305.5% | +53.2% | -38.9% | +271.3% | -87.4% | +135.6% | -14.7% | +107.8% | +26.2% | +34.3% | -92.0% | +145.3% | +376.6% | |
| – | – | – | +22.9% | +21.5% | +3.9% | +21.9% | +9.3% | -1.1% | -19.7% | -5.9% | -1.7% | -28.0% | +38.7% | -10.2% | +4.4% | +29.1% | +50.8% | -1.3% | -3.4% | +12.6% | +65.0% | +50.6% | +37.1% | +2.8% | -97.0% | |
| – | – | +34.6% | -7.2% | +27.1% | -33.7% | -64.9% | +335.6% | -8.8% | +556.5% | -96.8% | +55.2% | -802.1% | – | – | -805.6% | – | -265.4% | – | – | – | – | – | – | – | – | |
| – | +101.5% | +35.6% | +19.6% | +17.3% | +1.7% | +21.3% | +8.5% | +1.1% | -26.2% | -4.6% | -2.2% | -4.1% | +38.7% | -10.2% | +4.4% | +29.1% | +50.8% | -1.3% | -3.4% | +12.6% | +65.0% | +50.6% | +37.1% | +2.8% | +19.6% | |
| – | – | +17.9% | +31.8% | +30.9% | +8.2% | +17.5% | +9.7% | -9.8% | +3.6% | -9.1% | -4.3% | -13.8% | +28.8% | +14.4% | +13.9% | +41.5% | +31.1% | -14.2% | +26.6% | +33.4% | +83.3% | +83.9% | -2.5% | +24.0% | +32.0% | |
| – | +94.7% | +31.7% | +22.0% | +20.2% | +3.2% | +20.4% | +8.8% | -1.5% | -19.6% | -5.9% | -2.8% | -75.6% | +22.0% | +14.4% | +13.9% | +41.5% | +31.1% | -14.2% | +26.6% | +33.4% | +83.3% | +83.9% | -2.5% | +24.0% | +220.5% | |
| – | – | – | – | – | – | – | – | – | – | -290.2% | – | – | – | – | – | – | -706.8% | – | – | – | – | – | – | – | – | |
| – | +64.0% | +203.9% | +87.1% | -78.0% | -2.6% | -2.2% | +33.7% | -29.8% | -16.7% | -60.1% | -36.2% | -98.1% | +8,750.0% | -39.0% | -13.0% | +2,276.6% | +660.8% | +26.9% | +26.9% | +41.4% | -24.2% | +74.4% | +12.7% | +50.0% | +20.1% | |
| – | – | – | – | – | – | – | – | – | – | -300.3% | – | – | – | – | – | – | -876.7% | – | – | – | – | – | – | – | – | |
| – | +21.4% | -105.7% | – | – | – | – | – | – | – | -217.3% | – | – | – | – | – | – | – | +514.5% | +552.8% | +34.7% | -26.6% | -49.7% | -13.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -300.8% | – | – | – | – | – | – | -876.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -276.0% | – | – | – | – | – | – | -660.5% | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.